Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€34.35
22.12.22
-
22.12.23
13.25%
24.08.23

Finanzoo 
22.12.22 50%
buy
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€2.05
21.12.22
€4.00
31.12.24
-34.96%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
21.12.22 60%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.32
21.12.22
€11.00
31.03.24
29.21%
28.12.22

Could be very worthwhile Investment >20% year
BiotechBee 
21.12.22 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
19.12.22 70%
sell
Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition
Lokrim 
12.12.22 20%
sell
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation
me8 
12.12.22 0%
buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.39
12.12.22
€7.00
12.12.23
-60.16%
24.12.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Little innovation
me8 
12.12.22 0%
sell
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.98
12.12.22
-
12.12.23
1.61%
09.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
12.12.22 0%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.76
11.12.22
-
11.12.23
-6.82%
06.03.23

Could be worthwhile Investment >10% per year
bundfuture 
11.12.22 50%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€6.04
09.12.22
-
09.12.23
68.87%
10.12.23

DirectorDealer 
09.12.22 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€156.72
09.12.22
-
09.12.23
-11.18%
10.12.23

Joe130978 
09.12.22 50%
sell
Ipsen S.A.

Start price
Target price
Perf. (%)
€105.30
08.12.22
€100.00
08.12.23
-3.04%
09.12.22

Could be worthwhile Investment >10% per year
melinda 
08.12.22 20%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.24
08.12.22
-
08.12.23
-6.85%
24.12.22

Risky Investment
Vassago1 
08.12.22 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.20
07.12.22
-
07.12.23
-16.53%
10.12.22

Risky Investment
Vassago1 
07.12.22 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.29
06.12.22
-
06.12.23
-33.62%
07.12.23

DirectorDealer 
06.12.22 50%
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€72.50
02.12.22
-
02.12.23
22.69%
03.12.23

Lutz69 
02.12.22 50%
buy
BiondVax Pharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€9.38
30.11.22
€18.00
30.11.23
8.11%
12.12.22

DomRuinart 
30.11.22 50%
sell
CytoTools AG

Start price
Target price
Perf. (%)
€1.15
28.11.22
-
28.11.23
91.30%
24.04.23

Probably not worthwhile Investment
Lokrim 
28.11.22 20%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-1.66%
10.12.22

Risky Investment
thomasw 
28.11.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.13
28.11.22
-
28.11.23
-3.64%
12.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
28.11.22 0%
buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.22
-
27.11.23
-14.77%
11.12.22

Risky Investment
Wolf_of_WS 
27.11.22 50%
buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.72
22.11.22
-
22.11.23
-66.14%
23.11.23

Could be worthwhile Investment >10% per year
melinda 
22.11.22 20%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.58
21.11.22
-
21.11.23
-85.09%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Maxi_Scalibusa 
21.11.22 0%
sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
19.11.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
19.11.22 50%